novo nordisk glp-1 weight loss Nordisk, Eli Lilly cut drug costs under Medicare Novo Nordisk Drops Hims &

Pharmaceutics (2025) 17(4):477

Acetaminophen, via its reactive metabolite N-acetyl-p-benzo-quinoneimine and transient receptor potential ankyrin-1 stimulation, causes neurogenic inflammation in the airways and other tissues in rodents

[laughter] MH: Yeah

While the pharma industry attempts to expand the improved GLP-1 drug market, including orals, the generics industry will grow its GLP-1 agonist foothold, making cheaper and less efficacious injectable GLP-1 drugs much more widely available, rapidly growing the number of patients comfortable with self-injection for weight loss

An amylin analogue, pramlintide, was approved in 2005